Protect Pharmaceutical Corporation
PRTT
$1.22
-$0.08-6.15%
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Net Income | 89.53% | -107.68% | -194.00% | -369.97% | 77.51% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.37% | 695.28% | 611.27% | 1,843.86% | -81.42% |
| Change in Net Operating Assets | -45.04% | -65.16% | 61.19% | 273.61% | 211.90% |
| Cash from Operations | 101.79% | 100.83% | 100.00% | 100.00% | 80.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 277.36% | -- | -- | -100.00% | -79.77% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 277.36% | -- | -- | -100.00% | -79.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10,150.00% | 0.00% | -- | 100.00% | 90.48% |
